OTX008 structure
|
Common Name | OTX008 | ||
|---|---|---|---|---|
| CAS Number | 1638140-55-2 | Molecular Weight | 937.18 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C52H72N8O8 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of OTX008OTX008 (Calixarene 0118, PTX-008) is a calixarene derivative designed to bind the Galectin-1 (Gal1) amphipathic β-sheet conformation; inhibits Gal1 expression and ERK1/2 and AKT-dependent survival pathways, and induces G2/M cell cycle arrest through CDK1; inhibits proliferation and invasion at micromolar concentrations in cancer cells; inhibits growth of A2780-1A9 xenografts in vivo. Solid Tumors Phase 1 Clinical |
| Name | OTX008 |
|---|
| Description | OTX008 (Calixarene 0118, PTX-008) is a calixarene derivative designed to bind the Galectin-1 (Gal1) amphipathic β-sheet conformation; inhibits Gal1 expression and ERK1/2 and AKT-dependent survival pathways, and induces G2/M cell cycle arrest through CDK1; inhibits proliferation and invasion at micromolar concentrations in cancer cells; inhibits growth of A2780-1A9 xenografts in vivo. Solid Tumors Phase 1 Clinical |
|---|---|
| References | References 1. Dings RP, et al. J Med Chem. 2012 Jun 14;55(11):5121-9. 2. Astorgues-Xerri L, et al. Eur J Cancer. 2014 Sep;50(14):2463-77. 3. Dings RP, et al. Cancer Lett. 2008 Jul 8;265(2):270-80. 4. Zucchetti M, et al. Cancer Chemother Pharmacol. 2013 Oct;72(4):879-87. View Related Products by Target Galectin Solid Tumors |
| Molecular Formula | C52H72N8O8 |
|---|---|
| Molecular Weight | 937.18 |
| InChIKey | XYJZSUATWITWSG-UHFFFAOYSA-N |
| SMILES | CC1c2cccc(c2OCC(=O)NCCN(C)C)Cc2cccc(c2OCC(=O)NCCN(C)C)Cc2cccc(c2OCC(=O)NCCN(C)C)Cc2cccc1c2OCC(=O)NCCN(C)C |